Charles J. Casamento's Insider Trades & SAST Disclosures
Charles J. Casamento's most recent trade in Eton Pharmaceuticals Inc was a trade of 25,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Charles J. Casamento.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Oct 2024 | 13,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Purchase of securities on an exchange or from another person at price $ 2.56 per share. | 09 Sep 2024 | 13,000 | 13,000 (0%) | 0% | 2.6 | 33,280 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Other type of transaction at price $ 0.00 per share. | 24 May 2024 | 20,976 | 31,522 | - | - | Stock Option (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,976 | 52,498 | - | - | Stock Option (right to buy) | |
| PaxMedica Inc | Charles J. Casamento | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. | 12 Mar 2024 | 992 | 2,386 | - | 0.7 | 684 | Common Stock |
| Eton Pharmaceuticals Inc | Charles Casamento J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 30,000 | 164,555 | - | - | Stock Option (Right to buy) | |
| PaxMedica Inc | Casamento Charles J. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. | 29 Jan 2024 | 97 | 3,378 | - | 0.8 | 74 | Common Stock |
| First Wave BioPharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 19,633 | 19,937 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Casamento Charles J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 31,522 | 31,522 | - | - | Stock Option (right to buy) | |
| GT Biopharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 500,000 | 500,000 | - | - | Option to purchase Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 92,958 | 150,000 | - | - | Stock Option (right to buy) | |
| PaxMedica Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2023 | 14,000 | 65,583 | - | 0 | Common Stock | |
| Eton Pharmaceuticals Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 25,000 | 134,555 | - | - | Stock Option (Right to buy) | |
| First Wave BioPharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 84,745 | 85,134 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 10,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 57,042 | 57,042 | - | - | Stock Option (right to buy) | |
| PaxMedica Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 51,583 | 51,583 | - | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.24 per share. | 01 Apr 2022 | 19,800 | 19,800 (0%) | 0% | 3.2 | 64,152 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 19,800 | 77,511 | - | - | Stock Option (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 3,300 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 6,600 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 9,900 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 13,200 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 16,500 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 01 Apr 2022 | 3,300 | 0 (0%) | 0% | 29 | 95,700 | Common Stock |
| Eton Pharmaceuticals Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 50,000 | 109,555 | - | - | Stock Option (Right to buy) | |
| First Wave BioPharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 58,765 | 58,765 | - | - | Stock Option (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.60 per share. | 22 Sep 2021 | 10,000 | 16,600 (0%) | 0% | 4.6 | 46,000 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 22 Sep 2021 | 3,300 | 11,400 (0%) | 0% | 29 | 95,700 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 22 Sep 2021 | 1,900 | 14,700 (0%) | 0% | 29 | 55,100 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Sep 2021 | 1,900 | 97,311 | - | - | Options to purchase common stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 22 Sep 2021 | 1,400 | 10,000 (0%) | 0% | 29 | 40,600 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 10,000 | 102,500 | - | - | Options to purchase common stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.60 per share. | 17 Aug 2021 | 10,000 | 14,700 (0%) | 0% | 4.6 | 46,000 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 15 Jul 2021 | 2,136 | 5,854 (0%) | 0% | 31.0 | 66,272 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 32.49 per share. | 15 Jul 2021 | 1,164 | 4,700 (0%) | 0% | 32.5 | 37,816 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 33.19 per share. | 01 Jun 2021 | 2,480 | 6,950 (0%) | 0% | 33.2 | 82,300 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 01 Jun 2021 | 520 | 9,430 (0%) | 0% | 34.1 | 17,721 | Common Stock |
| Eton Pharmaceuticals Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 19,655 | 59,555 | - | - | Stock Option (Right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 03 May 2021 | 3,000 | 9,950 (0%) | 0% | 38.2 | 114,647 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 35.04 per share. | 01 Apr 2021 | 1,691 | 12,950 (0%) | 0% | 35.0 | 59,253 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 35.93 per share. | 01 Apr 2021 | 1,309 | 14,641 (0%) | 0% | 35.9 | 47,028 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 01 Mar 2021 | 3,000 | 15,950 (0%) | 0% | 33.9 | 101,618 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 33.90 per share. | 01 Feb 2021 | 1,663 | 18,950 (0%) | 0% | 33.9 | 56,376 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 33.30 per share. | 01 Feb 2021 | 1,337 | 20,613 (0%) | 0% | 33.3 | 44,522 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 100,000 | 100,000 | - | - | Options to purchase common stock | |
| First Wave BioPharma Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 41,237 | 41,237 | - | - | Options (right to buy) | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 32.11 per share. | 04 Jan 2021 | 3,000 | 21,950 (0%) | 0% | 32.1 | 96,342 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Nov 2020 | 21,223 | 27,950 (0%) | 0% | 0 | Common Stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 35.74 per share. | 24 Nov 2020 | 3,000 | 24,950 (0%) | 0% | 35.7 | 107,219 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 30.29 per share. | 02 Nov 2020 | 3,000 | 49,173 (0%) | 0% | 30.3 | 90,864 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 37.99 per share. | 01 Oct 2020 | 3,000 | 52,173 (0%) | 0% | 38.0 | 113,956 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 34.74 per share. | 01 Sep 2020 | 3,000 | 55,173 (0%) | 0% | 34.7 | 104,207 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.24 per share. | 18 Aug 2020 | 26,362 | 60,362 (0%) | 0% | 3.2 | 85,413 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2020 | 26,362 | 33,404 | - | - | Options to purchase common stock | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.03 per share. | 18 Aug 2020 | 2,189 | 58,173 (0%) | 0% | 39.0 | 85,437 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 35.74 per share. | 03 Aug 2020 | 3,000 | 34,000 (0%) | 0% | 35.7 | 107,213 | Common Stock |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Sale of securities on an exchange or to another person at price $ 43.89 per share. | 01 Jul 2020 | 3,000 | 37,000 (0%) | 0% | 43.9 | 131,677 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges